According to new research, a thick neck can be an accurate predictor of cardiovascular risk, as well as indicate type 2 ...

Once-weekly semaglutide 2.4 mg conferred a greater reduction in major adverse cardiovascular events than placebo, regardless ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

People on social media are now claiming that a man’s smile reveals more than just his pearly whites. The social media craze ...

Unisex braided wire bangle ( cuff bracelets) , rings and ear cuff - A little change, will come out different patterns - How ...

Higher socioenvironmental risk also equals a brain that looks older. Higher behavioral protective factors equal a younger ...

FOR those wondering if their upbringing had any bearing on the size of their member, scientists say for some people, it may ...

A large-scale study shows semaglutide reduces heart risks regardless of weight loss, suggesting the drug benefits ...

Using the weight loss jab Wegovy may help reduce a person’s risk of heart attack or stroke, regardless of how much weight ...

Research shows drug may protect heart through multiple mechanisms, suggesting benefits beyond obesity treatment - Anadolu ...

The cardiovascular benefits of weight loss drug semaglutide (Ozempic, Wegovy) occur regardless of how much weight a person loses or their starting body weight, new analysis suggests.1 Study authors ...

Dongfeng Gu and colleagues review community based cohort studies in China, finding strategies to improve the quality and scale of these studies in China and beyond Community based cohort studies ...